SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 136 filers reported holding SAGENT PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $4,683,000 | +17.4% | 312,575 | -4.6% | 0.00% | +100.0% |
| Q1 2016 | $3,989,000 | -32.6% | 327,742 | -11.9% | 0.00% | -50.0% |
| Q4 2015 | $5,916,000 | +7.5% | 371,865 | +3.6% | 0.00% | 0.0% |
| Q3 2015 | $5,501,000 | -26.1% | 358,833 | +17.3% | 0.00% | 0.0% |
| Q2 2015 | $7,439,000 | +28.0% | 305,999 | +22.4% | 0.00% | 0.0% |
| Q1 2015 | $5,813,000 | -6.1% | 250,010 | +1.4% | 0.00% | 0.0% |
| Q4 2014 | $6,189,000 | -22.0% | 246,468 | -3.4% | 0.00% | 0.0% |
| Q3 2014 | $7,932,000 | +32.0% | 255,033 | +9.7% | 0.00% | 0.0% |
| Q2 2014 | $6,011,000 | +1.0% | 232,427 | -8.7% | 0.00% | 0.0% |
| Q1 2014 | $5,949,000 | -15.0% | 254,537 | -7.7% | 0.00% | 0.0% |
| Q4 2013 | $6,999,000 | +42.1% | 275,763 | +14.2% | 0.00% | 0.0% |
| Q3 2013 | $4,925,000 | +41.9% | 241,409 | +46.0% | 0.00% | +100.0% |
| Q2 2013 | $3,470,000 | – | 165,385 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|